Overview
Status
Active
Registry date
2019-03-27
Share capital
10,000.00 PLN
Registered address
ul. Łukowa 3/6, 02-767 Warszawa, Poland
Financials
Data for 2024 is not shown: the filed document could not be read automatically.
Industry
- Manufacture of medical and dental instruments and supplies (32.5)
Authorized Representatives
Ewa Łukowska – Management Board Member
Mateusz Rosa Gawałkiewicz – President of the Management Board
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Andrzej Adam Chwojnowskiage 75 | 25 | $675.31 | 25% |
Ewa Łukowskaage 63 | 24 | $648.30 | 24% |
Mateusz Robert Rosa Gawałkiewiczage 38 | 51 | $1,377.63 | 51% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $19,154.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 9, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $4,731$4,731 | Fundacja Innowacyjna Polska | |
| Jun 9, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $4,731$4,731 | BTM Innovations sp. z o.o. | |
| Jun 4, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Lublin |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i AdministracjiResearch institute | $355,967,543.57 | cskmswia.pl | ||
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com | ||
| LASTsp. z o.o. | – | last-skincare.com |
Change history
| Date | Event | |
|---|---|---|
| 2020-06-05 | Address change (Ul. Gospodarcza 26, 20-213, Lublin → Ul. Łukowa 3/6, 02-767, Warszawa) | |
| 2019-03-27 | Entered in the register |
FAQ
The main business activity of Cartilago focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on March 27, 2019.
The headquarters is located at: ul. Łukowa 3, 02-767 Warszawa.
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-10-07